HANGZHOU JUST BIOTHERAPEUTICS (JUST CHINA)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company dedicated to accelerating the development of bio-medicine and significantly reducing manufacturing costs. Their core strengths are molecular design, process design, drug product design and manufacturing plant design.
HANGZHOU JUST BIOTHERAPEUTICS (JUST CHINA)
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.justbiochina.com
Total Employee:
51+
Status:
Closed
Contact:
+057128279502
Total Funding:
147.62 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apache Mobile Non Scaleable Content Euro Google Apps For Business GoDaddy DNS YouTube
Similar Organizations
Ark Bio
Ark Bio is a medical technology company
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Endymed
Endymed Ltd, formerly Applisonix Ltd, is an Israel-based company
Luqa Pharmaceuticals
Luqa Pharmaceuticals is a China-focused company.
Luxembourg Bio Technologies
Luxembourg Bio Technologies provides a comprehensive product to address peptide synthesis needs.
Novlead Biotech
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
QnQuality Pharmaceuticals
QnQuality Pharmaceuticals is a drug R&D company.
Ruiyi Biotechnology (Realbio Technology)
Ruiyi Biotechnology is a national high-tech enterprise.
Signia Therapeutics
Signia Therapeutics is an innovative French start-up company.
Current Advisors List
Advisor
Board_member
Advisor
Board_member
Advisor
Advisor
Current Employees Featured
Steve Landau Chief Medical Officer @ Hangzhou Just Biotherapeutics (Just China)
Chief Medical Officer
James Leung EVP for Recombinant Proteins @ Hangzhou Just Biotherapeutics (Just China)
EVP for Recombinant Proteins
Jonathan Zhao Co-Founder and Chairman @ Hangzhou Just Biotherapeutics (Just China)
Co-Founder and Chairman
Jerry Yang Sr. VP for Process and Product Development Biosimilar @ Hangzhou Just Biotherapeutics (Just China)
Sr. VP for Process and Product Development Biosimilar
Founder
Investors List
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Hangzhou Just Biotherapeutics (Just China)
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - Hangzhou Just Biotherapeutics (Just China)
Temasek Holdings
Temasek Holdings investment in Series B - Hangzhou Just Biotherapeutics (Just China)
BOCGI Zheshang Capital
BOCGI Zheshang Capital investment in Series B - Hangzhou Just Biotherapeutics (Just China)
Taikang Asset
Taikang Asset investment in Series B - Hangzhou Just Biotherapeutics (Just China)
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Hangzhou Just Biotherapeutics (Just China)
Temasek Holdings
Temasek Holdings investment in Series B - Hangzhou Just Biotherapeutics (Just China)
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Hangzhou Just Biotherapeutics (Just China)
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Hangzhou Just Biotherapeutics (Just China)
Taikang Life Insurance
Taikang Life Insurance investment in Series B - Hangzhou Just Biotherapeutics (Just China)
More informations about "Hangzhou Just Biotherapeutics (Just China)"
About us | HJB - Your Trusted Biologics CDMO Partner
× Xueming Qian. Co-Founder & CEO. Dr. Qian has over eighteen years of industrial antibody discovery and development experience. Before starting MABSPACE, Dr. Qian was Senior VP …See details»
HJB - Your Trusted Biologics CDMO Partner
Candidate selection based on molecule thermo stability and manufacturability; Early identification of potential critical quality attributes. Establish high titer bulk pools from DNA in 2 weeks for …See details»
Hangzhou Just Biotherapeutics (Just China) - Crunchbase
Contact Email media@justbiochina.com Phone Number +057128279502 Hangzhou Just Biotherapeutics is a comprehensive high-tech design company …See details»
CONTACT US | HJB - Your Trusted Biologics CDMO Partner
HJB Headquarter. Building 3, Hangzhou Pharmaceutical Town, No.291 Fucheng Road, Hangzhou, China . General business inquiry: CDMO@hjbbio.comSee details»
关于我们 | 奕安济世 - 值得信赖的大分子药物CDMO
奕安济世是创胜集团的附属子公司，致力于为大分子药物提供 优质、可靠、快速的 cdmo 完整服务。. 在奕安济世，我们采用一流的集成化技术平台，极大加速开发进程和降低生产成本，促进产品快速商业化。See details»
Hangzhou Just Biotherapeutics - PitchBook
Aug 1, 2016 Hangzhou Just Biotherapeutics General Information Description. Developer of a technology designed to offer global antibody and recombinant protein bio-therapeutics. The company's technology uses protein, process and …See details»
Hangzhou Just Biotherapeutics, Ltd. Secures Closing of Series B …
Aug 8, 2017 For more information on Just, please visit www.justbiochina.com. About Temasek. Incorporated in 1974, Temasek is an investment company headquartered in Singapore.See details»
Hangzhou Just Biotherapeutics - Overview, News & Similar
View Hangzhou Just Biotherapeutics (www.justbiochina.com) location in Zhejiang, China , revenue, industry and description. Find related and similar companies as well as employees …See details»
Hangzhou Just Biotherapeutics (Just China) Company Information ...
Get information on funding, investors, industries, and more for Hangzhou Just Biotherapeutics (Just China). See Hangzhou Just Biotherapeutics (Just China) company profile and funding data.See details»
The Just China Story: Building a State of the Art ... - YouTube
Mar 26, 2018 Just Biotherapeutics (Just), its affiliated company, Hangzhou Just Biotherapeutics (Just China) and G-CON Manufacturing worked together on Just China’s state...See details»
The Just China Story: Building a State of the Art ... - gcon
Mar 26, 2018 The Just China Story: Building a State of the Art Biomanufacturing Facility. Just Biotherapeutics (Just), its affiliated company, Hangzhou Just Biotherapeutics (Just China) and G-CON Manufacturing worked together on …See details»
About us | HJB - Your Trusted Biologics CDMO Partner
HJB was established by a seasoned team with expertise across protein, process, and manufacturing sciences. Our mission is to overcome scientific and technical barriers that …See details»
HJB Achieves Breakthrough Volumetric Productivity of 8 g/L-day in ...
HANGZHOU, China, January 26, 2024 – HJB is excited to announce a major breakthrough in its Highly Intensified Continuous Bioprocessing (HiCB) platform. Utilizing its proprietary ExcelPro …See details»
奕健生物-动脉网 - vbdata.cn
Feb 3, 2016 luanhong.wu@justbiochina.com. 杭州奕健生物科技有限公司是一家全球生物治疗公司，完全整合基于抗体的生物治疗药物发现，研发和制造，专注于开发创新抗体以帮助更多患 …See details»
HJB Achieves Major Milestone in Continuous Perfusion Cell Culture ...
Dedicated to innovative process and continuous manufacturing of biologics and providing high quality, reliable and efficient CDMO services to partners, HJB today announced it has …See details»
About us | HJB - Your Trusted Biologics CDMO Partner
HJB was founded by an experienced team spanning the fields of protein, process and manufacturing sciences. We aim to break the scientific and technical hurdles inhibiting …See details»
公司新闻 | 奕安济世 - 值得信赖的大分子药物CDMO
双特异性抗体（简称双抗；Bispecific Antibody，BsAb），是通过重组DNA或细胞融合等生物技术制备的人工抗体，可以同时或先后特异性结合两种靶抗原或同一靶抗原的两个不同表位。See details»
News | HJB - Your Trusted Biologics CDMO Partner
Official website of HJB(Hang Zhou) Co.,Ltd. HANGZHOU, China, September 12, 2024 – The recombinant humanized anti-EGFR-CD3 enzyme-controlled bispecific antibody (hereinafter …See details»
奕安济世助力合作伙伴确证性临床试验阶段生产连续灌流工艺变更 …
奕安济世助力合作伙伴关键项目于2022年4月获得中国NMPA确证性临床试验阶段生产工艺变更批准，该项目于2020年先后获得FDA和NMPA的IND批准，根据临床研究进展，客户要求加速项 …See details»
服务项目 | 奕安济世 - 值得信赖的大分子药物CDMO
通过高产的稳定细胞群，我们能够快速完成实验室规模的早期抗体小样制备。从转染到克级抗体蛋白，整个过程仅需约 6 周。See details»